A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33

By Matsueda Satoko   Yamada Akira   Takao Yukari   Tamura Mayumi   Komatsu Nobukazu   Yutani Shigeru   Ide Tatsuya   Sata Michio   Itoh Kyogo  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. : 1359-1366

Springer Publishing Company

Access to resources Recommend Favorite

Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope

By Thorn Mette   Wang Mingjun   Kløverpris Henrik   Schmidt Esben   Fomsgaard Anders   Wenandy Lynn   Berntsen Annika   Brunak Søren   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1755-1763

Springer Publishing Company

Access to resources Recommend Favorite

Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients

By Ugurel Selma   Uhlig Dario   Pföhler Claudia   Tilgen Wolfgang   Schadendorf Dirk   Reinhold Uwe  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 551-559

Springer Publishing Company

Access to resources Recommend Favorite

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

By Han Jun-Feng   Zhao Ting-Ting   Liu Hong-Li   Lin Zhi-Hua   Wang Hui-Ming   Ruan Zhi-Hua   Zou Li-Yun   Wu Yu-Zhang  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1575-1583

Springer Publishing Company

Access to resources Recommend Favorite

Peptide FLNPDVLDI of heparanase is a novel HLA-A2-restricted CTL epitope and elicits potent immunological antitumor effects in vitro with an 8-branched design

By            

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1955-1961

Spandidos Publications

Access to resources Recommend Favorite